Skip to main content
Clinical Trials/NCT00944853
NCT00944853CompletedNot Applicable

The Effect of Zinc Supplementation, Provided as Either a Liquid Zinc Solution or Dispersible Tablets, on Plasma Zinc Concentration Among Young Burkinabe Children

University of California, Davis1 site in 1 country462 target enrollmentStarted: August 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
462
Locations
1
Primary Endpoint
Plasma zinc concentration

Study Overview

Brief Summary

The study aims to compare the effects of two different formulations of zinc supplements on plasma zinc concentrations among young Burkinabe children.

Detailed Description

  1. To investigate the effects of short-term zinc supplementation, provided either as a dispersible tablet containing zinc sulfate ("ZinCfant," Nutriset Ltd; Malaunay, France) or as a liquid ZnSO4 solution, on changes in serum zinc concentration, compared with a placebo in young Burkinabe children; and 2) to assess the relationship between change in serum zinc concentration and the presence of altered intestinal permeability within each treatment group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
6 Months to 23 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •currently breast feeding
  • •informed consent of a parent or guardian.

Exclusion Criteria

  • •symptomatic acute or chronic febrile infections
  • •diarrhea within the past week
  • •consuming vitamin or mineral supplements or zinc-fortified infant formulas

Arms & Interventions

Zinc syrup

Experimental

Liquid Zinc Syrup (ZnSO4) solution provided daily

Intervention: Liquid zinc syrup (Dietary Supplement)

Zinc tablet

Experimental

Dispersible zinc tablets provided daily

Intervention: Zinc tablet (Dietary Supplement)

Placebo

Placebo Comparator

Liquid placebo supplement provided daily

Intervention: Liquid placebo supplement (Dietary Supplement)

Outcomes

Primary Outcomes

Plasma zinc concentration

Time Frame: 3 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials